CORD-19:35349bb1fc9290338907b7d7f104c9db3951163b / 508-699 JSONTXT

Annnotations TAB JSON ListView MergeView

    CORD-19-Sentences

    {"project":"CORD-19-Sentences","denotations":[{"id":"TextSentencer_T3","span":{"begin":0,"end":191},"obj":"Sentence"},{"id":"T15907","span":{"begin":0,"end":191},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Angiotensin converting enzyme inhibitors (ACEi) are standard of care for treatment of congestive heart failure, but aldosterone breakthrough occurs when ACEi are used in both dogs and humans."}

    CORD-19-PD-UBERON

    {"project":"CORD-19-PD-UBERON","denotations":[{"id":"T3","span":{"begin":97,"end":102},"obj":"Body_part"}],"attributes":[{"id":"A3","pred":"uberon_id","subj":"T3","obj":"http://purl.obolibrary.org/obo/UBERON_0000948"}],"text":"Angiotensin converting enzyme inhibitors (ACEi) are standard of care for treatment of congestive heart failure, but aldosterone breakthrough occurs when ACEi are used in both dogs and humans."}

    CORD-19-PD-MONDO

    {"project":"CORD-19-PD-MONDO","denotations":[{"id":"T3","span":{"begin":86,"end":110},"obj":"Disease"},{"id":"T4","span":{"begin":97,"end":110},"obj":"Disease"},{"id":"T40360","span":{"begin":86,"end":110},"obj":"Disease"},{"id":"T20146","span":{"begin":97,"end":110},"obj":"Disease"}],"attributes":[{"id":"A3","pred":"mondo_id","subj":"T3","obj":"http://purl.obolibrary.org/obo/MONDO_0005009"},{"id":"A4","pred":"mondo_id","subj":"T4","obj":"http://purl.obolibrary.org/obo/MONDO_0005252"},{"id":"A22276","pred":"mondo_id","subj":"T40360","obj":"http://purl.obolibrary.org/obo/MONDO_0005009"},{"id":"A90626","pred":"mondo_id","subj":"T20146","obj":"http://purl.obolibrary.org/obo/MONDO_0005252"}],"text":"Angiotensin converting enzyme inhibitors (ACEi) are standard of care for treatment of congestive heart failure, but aldosterone breakthrough occurs when ACEi are used in both dogs and humans."}

    CORD-19-PD-HP

    {"project":"CORD-19-PD-HP","denotations":[{"id":"T1","span":{"begin":86,"end":110},"obj":"Phenotype"}],"attributes":[{"id":"A1","pred":"hp_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/HP_0001635"}],"text":"Angiotensin converting enzyme inhibitors (ACEi) are standard of care for treatment of congestive heart failure, but aldosterone breakthrough occurs when ACEi are used in both dogs and humans."}